Clinical

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cancer prevention through weight loss: emulating a target trial and mediation analysis

GENERATION: Improving the efficiency and equity of tumour-agnostic clinical trial recruitment using automated electronic record based tools

Functional dissection of myelodysplastic syndrome disease progression

Investigating the role of semaglutide (GLP-1 receptor agonist) in the medical management of atypical endometrial hyperplasia and endometrial cancer

Developing novel therapeutics to target splicing factor mutant myeloid malignancies

Identifying epigenetic regulatory mechanisms conferring chemotherapeutic drug resistance in oesophageal adenocarcinoma

Deep profiling of non-small cell lung cancer clinical samples to identify and validate novel mechanisms of resistance to KRAS inhibition

The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer

Beyond BRCA1/2: dissecting drivers of chromosome instability in high-grade serous ovarian cancer